Atlas Trials

Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia

Clinical trial NCT01377233 · COMPLETED

Trial details

NCT number
NCT01377233
Sponsor
H. Lundbeck A/S
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2011-07-01
Primary completion
2012-02-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.